Predicting a rare but life-altering complication of common cancer treatment

A new study published in the Journal of Clinical Investigation has identified biomarkers that predict the likelihood of a patient developing checkpoint inhibitor-associated autoimmune diabetes before they are treated with immune checkpoint…

Continue Reading

News Source: medicalxpress.com